GT Biopharma, Inc.
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company developing innovative immuno-oncology therapies designed to harness the power of the body’s immune system to fight cancer. The company’s research is centered on its proprietary TriKE® (Tri-specific Killer Engager) platform, which activates and enhances the cancer-killing activity of natural killer (NK) immune cells. The TriKE® platform is engineered to stimulate NK cell proliferation and direct targeted immune responses against tumor cells. GT Biopharma holds an exclusive worldwide license agreement with the University of Minnesota to develop and commercialize therapies based on this technology, advancing a pipeline of next-generation immunotherapies aimed at improving treatment outcomes for patients with cancer.
Company News|Latest News, Press and Market Commentary
Bloomberg|News
CNBC|News
Market Chart
GT Biopharma, Inc.
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company developing innovative immuno-oncology therapies designed to harness the power of the body’s immune system to fight cancer. The company’s research is centered on its proprietary TriKE® (Tri-specific Killer Engager) platform, which activates and enhances the cancer-killing activity of natural killer (NK) immune cells.The TriKE® platform is engineered to stimulate NK cell proliferation and direct targeted immune responses against tumor cells. GT Biopharma holds an exclusive worldwide license agreement with the University of Minnesota to develop and commercialize therapies based on this technology, advancing a pipeline of next-generation immunotherapies aimed at improving treatment outcomes for patients with cancer
Market Summary
Biotechnology sector driven by innovation in therapeutics and life sciences.
Strong institutional interest due to high-growth and breakthrough potential.
Pipeline-driven valuations with catalysts tied to clinical milestones.
Advancements in immunotherapy and precision medicine shaping sector growth.
Industry Insights
Biotechnology companies play a critical role in advancing global healthcare innovation.
Firms focus on developing new therapeutics, diagnostics, and biomedical technologies.
The sector is driven by breakthroughs in immunotherapy and precision medicine.
Clinical trial results and regulatory approvals act as major valuation catalysts.
Institutional capital is attracted by long-term growth and innovation potential.
Biotech sits at the forefront of next-generation medical and scientific advancement.
Industry Leaders
Eli Lilly
LLYGlobal pharmaceutical leader in obesity, diabetes, and oncology.
Novo Nordisk
NVOLeader in diabetes care and GLP-1 therapies.
Johnson & Johnson
JNJDiversified healthcare and pharmaceutical giant.
Merck & Co.
MRKOncology and vaccine powerhouse (Keytruda).
AbbVie
ABBVImmunology and oncology-focused biopharma company.
Amgen
AMGNBiotech leader in biologics and biosimilars.
Gilead Sciences
GILDAntiviral and oncology-focused biotech.
Regeneron Pharmaceuticals
REGNInnovative biotech in immunology and eye care.
Vertex Pharmaceuticals
VRTXLeader in cystic fibrosis and gene-based therapies.
Moderna
MRNAmRNA platform biotechnology company.
Sector Stocks
Replimune Group
REPLOncolytic immunotherapy development.
ORIC Pharmaceuticals
ORICTargeted cancer therapies.
Anixa Biosciences
ANIXCancer immunotherapy and vaccines.
ImmunityBio
IBRXCell-based immunotherapy platform.
Iovance Biotherapeutics
IOVATumor-infiltrating lymphocyte therapies.
Precigen
PGENGene and cell therapy platform.
Exelixis
EXELCancer-focused biotech therapeutics.
Incyte
INCYOncology and inflammation treatments.
BridgeBio Pharma
BBIOGenetic disease therapeutics.
Krystal Biotech
KRYSGene therapy innovation.
Kymera Therapeutics
KYMRTargeted protein degradation platform.
Moderna
MRNAmRNA-based therapeutics and vaccines.
Regeneron Pharmaceuticals
REGNBiologic drug development leader.
Vertex Pharmaceuticals
VRTXGenetic disease therapies.
BioMarin Pharmaceutical
BMRNRare disease treatments.
Alnylam Pharmaceuticals
ALNYRNA interference therapeutics.
Trading Platforms
TradingView
Advanced charting and technical analysis platform.
Interactive Brokers
Global trading across equities, options, and futures.
eToro
Social trading and multi-asset investing platform.
TD Ameritrade
Retail trading with thinkorswim tools.
Charles Schwab
Full-service brokerage and investment platform.
Robinhood
Commission-free trading app for retail investors.
Trade Republic
European mobile-first investing platform offering stocks, ETFs, and savings plans.
Stash
Beginner-friendly investing app with automated portfolios and education tools.
TradeStation
Advanced trading platform with powerful analytics and execution tools.
XS.com
Global multi-asset broker offering forex, commodities, and indices trading.
CityFalcon
AI-driven financial news aggregation and market intelligence platform.
Webull
Mobile-first trading with advanced analytics.
Plus500
CFD trading platform for global markets.